Clinical Trial Update: POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis) [Phase 4]

View source ↗

Summary

Phase 4 trial update for the POPULAR study evaluating patient preference using levocetirizine in seasonal allergic rhinitis; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• XYZAL (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

Sponsor: UCB Pharma | Conditions: Seasonal Allergic Rhinitis | Phase 4 | Status: COMPLETED